|
Required | NCEP ATP3 2005 | IDF 2006 Waist = 94 cm (men) or = 80 cm (women) | EGIR 1999 Insulin resistance or fasting hyperinsulinemia in top 25 percent | WHO 1999 | AACE 2003 High risk of insulin resistance; or BMI = 25 kg/m2; or waist = 102 cm (men) or = 88 cm (women) |
Insulin resistance in top 25 percent; |
glucose = 6.1 mmol/L (110 mg/dL); |
2-hour glucose = 7.8 mmol/L (140 mg/dL) |
|
Number of abnormalities | 3 | 2 | 2 | 2 | 2 |
Glucose | mmol/L (100 mg/dL) | 5.6 mmol/L (100 mg/dL) | 6.1–6.9 mmol/L (110–125 mg/dL) | | 6.1 mmol/L (110 mg/dL); |
| or drug treatment for elevated blood glucose | or diagnosed diabetes | | | 2-hour glucose 7.8 mmol/L (140 mg/dL) |
HDL cholesterol | <1.0 mmol/L (40 mg/dL) (men); | <1.0 mmol/L (40 mg/dL) (men); | <1.0 mmol/L (40 mg/dL) | <0.9 mmol/L (35 mg/dL) (men); <1.0 mmol/L (40 mg/dL) (women) | <1.0 mmol/L (40 mg/dL) (men); |
| <1.3 mmol/L (50 mg/dL) (women); | <1.3 mmol/L (50 mg/dL) (women); | | <1.3 mmol/L (50 mg/dL) (women) |
| or drug treatment for low HDL-C | or drug treatment for low HDL-C | | |
Triglycerides | 1.7 mmol/L (150 mg/dL) | 1.7 mmol/L (150 mg/dL) | 2.0 mmol/L (180 mg/dL) | 1.7 mmol/L (150 mg/dL) | 1.7 mmol/L (150 mg/dL) |
| or drug treatment for elevated triglycerides | or drug treatment for high triglycerides | or drug treatment for dyslipidemia | | |
Obesity | Waist = 102 cm (men) | | Waist = 94 cm (men) | Waist/hip ratio > 0.9 (men) | |
| or = 88 cm (women) | | or = 80 cm (women) | or >0.85 (women) | |
| | | | or BMI = 30 kg/m2 | |
Hypertension | 130/85 mmHg | 130/85 mmHg | 140/90 mmHg | 140/90 mmHg | 130/85 mmHg |
| or drug treatment for hypertension | or drug treatment for hypertension | or drug treatment for hypertension | | |
|